The effect of specialized continuous renal replacement therapy team in acute kidney injury patients treatment

Yonsei Med J. 2015 May;56(3):658-65. doi: 10.3349/ymj.2015.56.3.658.

Abstract

Purpose: Continuous renal replacement therapy (CRRT) has been established for critically ill acute kidney injury (AKI) patients. In addition, some centers consist of a specialized CRRT team (SCT) with physicians and nurses. To our best knowledge, however, ona a few studies have yet been carried out on the superiority of SCT management.

Materials and methods: A total of 551 patients, who received CRRT between January 2008 and March 2009, were divided into two groups based on the controller of CRRT. The impact of the CRRT management on 28-day mortality was compared between two groups by Kaplan-Meier curve and Cox analysis.

Results: During the study period, the number of filters used, down-time per day, and intensive care unit length of day were significantly higher in non-SCT group than in SCT group (6.2 hrs vs. 5.0 hrs, p=0.042; 5.0 hrs vs. 3.8 hrs, p<0.001; 27.5 days vs. 21.1 days, p=0.027, respectively), while net ultrafiltration rate was significantly lower in non-SCT group than SCT group (28.0 mL/kg/hr vs. 29.5 mL/kg/hr, p=0.043, respectively). In addition, 28-day mortality rate was significantly lower in SCT group than with non-SCT group (p=0.031). Moreover, Cox regression analysis showed that 28-day mortality rate was significantly lower in SCT control group, even after adjusting for age, gender, severity scores, biomarkers, risk, injury, failure, loss, and end-stage renal disease, and contributing factors (hazard ratio 0.91, p=0.046).

Conclusion: A well-trained CRRT team could be beneficial for mortality improvement of AKI patients requiring CRRT.

Keywords: 28-day mortality; SCT management; acute kidney injury; continuous renal replacement therapy.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / mortality
  • Acute Kidney Injury / therapy*
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers
  • Critical Illness / mortality*
  • Critical Illness / therapy
  • Female
  • Humans
  • Intensive Care Units
  • Kaplan-Meier Estimate
  • Kidney Failure, Chronic / therapy*
  • Male
  • Middle Aged
  • Patient Care Team
  • Proportional Hazards Models
  • Renal Replacement Therapy / methods*
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers